| Year |
Citation |
Score |
| 2023 |
Rizzo MG, De Plano LM, Palermo N, Franco D, Nicolò M, Sciuto EL, Calabrese G, Oddo S, Conoci S, Guglielmino SPP. A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2301650. PMID 37150869 DOI: 10.1002/advs.202301650 |
0.401 |
|
| 2023 |
De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A. The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities. Biomolecules. 13. PMID 36979483 DOI: 10.3390/biom13030549 |
0.405 |
|
| 2022 |
Engelender S, Stefanis L, Oddo S, Bellucci A. Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35579450 DOI: 10.1002/mds.29058 |
0.311 |
|
| 2019 |
Vartak RS, Rodin A, Oddo S. Differential activation of the mTOR/autophagy pathway predicts cognitive performance in APP/PS1 mice. Neurobiology of Aging. 83: 105-113. PMID 31585361 DOI: 10.1016/j.neurobiolaging.2019.08.018 |
0.357 |
|
| 2019 |
Velazquez R, Ferreira E, Knowles S, Fux C, Rodin A, Winslow W, Oddo S. Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation. Aging Cell. e13037. PMID 31560162 DOI: 10.1111/Acel.13037 |
0.45 |
|
| 2019 |
Velazquez R, Ferreira E, Winslow W, Dave N, Piras IS, Naymik M, Huentelman MJ, Tran A, Caccamo A, Oddo S. Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations. Molecular Psychiatry. PMID 30622336 DOI: 10.1038/S41380-018-0322-Z |
0.337 |
|
| 2018 |
Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Oddo S. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Aging Cell. e12873. PMID 30488653 DOI: 10.1111/Acel.12873 |
0.492 |
|
| 2018 |
Velazquez R, Ferreira E, Tran A, Turner EC, Belfiore R, Branca C, Oddo S. Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits. Aging Cell. e12775. PMID 29749079 DOI: 10.1111/Acel.12775 |
0.376 |
|
| 2018 |
Caccamo A, Belfiore R, Oddo S. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease. Neurobiology of Aging. 68: 59-67. PMID 29729422 DOI: 10.1016/j.neurobiolaging.2018.03.032 |
0.417 |
|
| 2018 |
Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT. Corrigendum to "Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease" [Neurobiol. Aging 58 (2017) 1-13]. Neurobiology of Aging. 65: 235-238. PMID 29580440 DOI: 10.1016/J.Neurobiolaging.2018.02.010 |
0.364 |
|
| 2018 |
Caccamo A, Branca C, Oddo S. S3-02-01: Necroptosis Activation In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2735 |
0.383 |
|
| 2017 |
Branca C, Ferreira E, Nguyen TV, Doyle K, Caccamo A, Oddo S. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease. Human Molecular Genetics. PMID 29036636 DOI: 10.1093/Hmg/Ddx361 |
0.436 |
|
| 2017 |
Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT. Corrigendum to "Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease" [Neurobiol. Aging 58 (2017) 1-13]. Neurobiology of Aging. 58: 241. PMID 28863813 DOI: 10.1016/J.Neurobiolaging.2017.08.011 |
0.364 |
|
| 2017 |
Branca C, Shaw DM, Belfiore R, Gokhale V, Shaw AY, Foley C, Smith B, Hulme C, Dunckley T, Meechoovet B, Caccamo A, Oddo S. Dyrk1 inhibition improves Alzheimer's disease-like pathology. Aging Cell. PMID 28779511 DOI: 10.1111/Acel.12648 |
0.511 |
|
| 2017 |
Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN, Belfiore R, Winslow W, Oddo S. Necroptosis activation in Alzheimer's disease. Nature Neuroscience. PMID 28758999 DOI: 10.1038/Nn.4608 |
0.607 |
|
| 2017 |
Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S, Dineley KT. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease. Neurobiology of Aging. 58: 1-13. PMID 28688899 DOI: 10.1016/J.Neurobiolaging.2017.06.003 |
0.31 |
|
| 2017 |
Oddo S, Caccamo A, Branca C. [P2-177]: NECROPTOSIS AS A NOVEL MECHANISM UNDERLYING NEURONAL LOSS IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P674-P674. DOI: 10.1016/J.Jalz.2017.06.828 |
0.4 |
|
| 2017 |
Caccamo A, Branca C, Ferreira E, Oddo S. [P2-156]: INCREASED SUSCEPTIBILITY TO NECROPTOSIS IN APP/PS1 MICE Alzheimer's & Dementia. 13: P667-P667. DOI: 10.1016/J.Jalz.2017.06.807 |
0.381 |
|
| 2016 |
Norambuena A, Wallrabe H, McMahon L, Silva A, Swanson E, Khan SS, Baerthlein D, Kodis E, Oddo S, Mandell JW, Bloom GS. mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693185 DOI: 10.1016/J.Jalz.2016.08.015 |
0.362 |
|
| 2016 |
Caccamo A, Ferreira E, Branca C, Oddo S. p62 improves AD-like pathology by increasing autophagy. Molecular Psychiatry. PMID 27573878 DOI: 10.1038/mp.2016.139 |
0.456 |
|
| 2016 |
Velazquez R, Shaw DM, Caccamo A, Oddo S. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease. Molecular Neurodegeneration. 11: 52. PMID 27412291 DOI: 10.1186/S13024-016-0118-Z |
0.472 |
|
| 2016 |
Ferreira E, Shaw DM, Oddo S. Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease. Translational Psychiatry. 6: e849. PMID 27378549 DOI: 10.1038/tp.2016.114 |
0.393 |
|
| 2016 |
Norambuena A, Wallrabe H, McMahon L, Silva A, Swanson E, Khan S, Baerthlein D, Kodis E, Oddo S, Mandell JW, Bloom GS. P3-120: Dysregulated MTOR Signaling is a Seminal Step in Alzheimer's Disease Pathogenesis Alzheimer's & Dementia. 12: P865-P865. DOI: 10.1016/J.Jalz.2016.06.1778 |
0.4 |
|
| 2015 |
Talboom JS, Velazquez R, Oddo S. The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease. Npj Aging and Mechanisms of Disease. 1: 15008. PMID 28721257 DOI: 10.1038/npjamd.2015.8 |
0.325 |
|
| 2015 |
Mastroeni D, Delvaux E, Nolz J, Tan Y, Grover A, Oddo S, Coleman PD. Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease. Neurobiology of Aging. 36: 3121-9. PMID 26553823 DOI: 10.1016/J.Neurobiolaging.2015.08.017 |
0.467 |
|
| 2015 |
Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, Messina A, Huang Z, Wu J, Oddo S. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14042-56. PMID 26468204 DOI: 10.1523/Jneurosci.2781-15.2015 |
0.54 |
|
| 2015 |
Caccamo A, Shaw DM, Guarino F, Messina A, Walker AW, Oddo S. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43. Human Molecular Genetics. 24: 4625-35. PMID 26002100 DOI: 10.1093/Hmg/Ddv193 |
0.39 |
|
| 2015 |
Richardson A, Galvan V, Lin AL, Oddo S. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story. Experimental Gerontology. 68: 51-8. PMID 25481271 DOI: 10.1016/J.Exger.2014.12.002 |
0.517 |
|
| 2015 |
Oddo S, Caccamo A, Talboom JS, Branca C. O2-12-02: Reducing ribosomal protein s6 kinase 1 ameliorates Alzheimer's disease-like cognitive and synaptic deficits by reducing bace-1 translation Alzheimer's & Dementia. 11: P203-P203. DOI: 10.1016/J.Jalz.2015.07.196 |
0.375 |
|
| 2015 |
Talboom JS, Orr M, Caccamo A, Oddo S. P3-043: Chemogenetic facilitation of neuronal depolarization ameliorates Alzheimer's disease-like cognitive deficits Alzheimer's & Dementia. 11: P634-P635. DOI: 10.1016/J.Jalz.2015.06.909 |
0.397 |
|
| 2015 |
Norambuena A, Wallrabe H, McMahon L, Swanson E, Thomas S, Baerthlein D, Silva A, Oddo S, Mandell JW, Bloom GS. P3-035: Mtor and rac1 control-induced, tau-dependent cell cycle re-entry in Alzheimer's disease neurons: A mechanistic explanation for classifying Alzheimer's disease as type 3 diabetes Alzheimer's & Dementia. 11: P632-P632. DOI: 10.1016/J.Jalz.2015.06.901 |
0.436 |
|
| 2014 |
Branca C, Wisely EV, Hartman LK, Caccamo A, Oddo S. Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease. Neurobiology of Aging. 35: 2726-35. PMID 25034342 DOI: 10.1016/J.Neurobiolaging.2014.06.011 |
0.562 |
|
| 2014 |
Caccamo A, De Pinto V, Messina A, Branca C, Oddo S. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7988-98. PMID 24899720 DOI: 10.1523/Jneurosci.0777-14.2014 |
0.503 |
|
| 2014 |
Wisely EV, Xiang YK, Oddo S. Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies. Human Molecular Genetics. 23: 4024-34. PMID 24626633 DOI: 10.1093/Hmg/Ddu116 |
0.56 |
|
| 2014 |
Orr ME, Salinas A, Buffenstein R, Oddo S. Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology. Neurobiology of Aging. 35: 1233-42. PMID 24411482 DOI: 10.1016/J.Neurobiolaging.2013.12.006 |
0.444 |
|
| 2014 |
Edrey YH, Oddo S, Cornelius C, Caccamo A, Calabrese V, Buffenstein R. Oxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents. Journal of Neuroscience Research. 92: 195-205. PMID 24273049 DOI: 10.1002/Jnr.23320 |
0.333 |
|
| 2014 |
Medina DX, Orr ME, Oddo S. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice. Neurobiology of Aging. 35: 79-87. PMID 23954172 DOI: 10.1016/J.Neurobiolaging.2013.07.006 |
0.416 |
|
| 2014 |
Caccamo A, Oddo S. O2-12-03: GENETIC REDUCTION OF MTOR SIGNALING AMELIORATES ALZHEIMER'S DISEASE-RELATED COGNITIVE DEFICITS AND AMYLOID-B PATHOLOGY BY RESTORING HIPPOCAMPAL GENE EXPRESSION SIGNATURE Alzheimer's & Dementia. 10: P192-P192. DOI: 10.1016/J.Jalz.2014.04.224 |
0.513 |
|
| 2013 |
Orr ME, Oddo S. Autophagic/lysosomal dysfunction in Alzheimer's disease. Alzheimer's Research & Therapy. 5: 53. PMID 24171818 DOI: 10.1186/Alzrt217 |
0.507 |
|
| 2013 |
Edrey YH, Medina DX, Gaczynska M, Osmulski PA, Oddo S, Caccamo A, Buffenstein R. Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease. Neurobiology of Aging. 34: 2352-60. PMID 23618870 DOI: 10.1016/J.Neurobiolaging.2013.03.032 |
0.552 |
|
| 2013 |
Wang D, Fu Q, Zhou Y, Xu B, Shi Q, Igwe B, Matt L, Hell JW, Wisely EV, Oddo S, Xiang YK. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models. The Journal of Biological Chemistry. 288: 10298-307. PMID 23430246 DOI: 10.1074/Jbc.M112.415141 |
0.516 |
|
| 2013 |
Caccamo A, Magrì A, Medina DX, Wisely EV, López-Aranda MF, Silva AJ, Oddo S. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell. 12: 370-80. PMID 23425014 DOI: 10.1111/Acel.12057 |
0.486 |
|
| 2013 |
Caccamo A, Medina DX, Oddo S. Glucocorticoids exacerbate cognitive deficits in TDP-25 transgenic mice via a glutathione-mediated mechanism: implications for aging, stress and TDP-43 proteinopathies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 906-13. PMID 23325230 DOI: 10.1523/Jneurosci.3314-12.2013 |
0.372 |
|
| 2013 |
Walker MP, LaFerla FM, Oddo SS, Brewer GJ. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Age (Dordrecht, Netherlands). 35: 519-31. PMID 22237558 DOI: 10.1007/s11357-011-9375-5 |
0.574 |
|
| 2013 |
Orr M, Oddo S. P1-105: The role of autophagy in Alzheimer's disease Alzheimer's & Dementia. 9: P189-P189. DOI: 10.1016/J.Jalz.2013.05.327 |
0.416 |
|
| 2013 |
Oddo S. O2-01-05: The relationship among mTOR, beta-amyloid and tau: Therapeutic implications for Alzheimer's disease Alzheimer's & Dementia. 9: P315-P315. DOI: 10.1016/J.Jalz.2013.04.139 |
0.475 |
|
| 2012 |
Yan XX, Cai Y, Shelton J, Deng SH, Luo XG, Oddo S, Laferla FM, Cai H, Rose GM, Patrylo PR. Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice. Plos One. 7: e48782. PMID 23155407 DOI: 10.1371/Journal.Pone.0048782 |
0.685 |
|
| 2012 |
Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Oddo S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496 |
0.434 |
|
| 2012 |
Takamura A, Sato Y, Watabe D, Okamoto Y, Nakata T, Kawarabayashi T, Oddo S, Laferla FM, Shoji M, Matsubara E. Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways. Life Sciences. 91: 1177-86. PMID 22579764 DOI: 10.1016/J.Lfs.2012.04.038 |
0.647 |
|
| 2012 |
Cotella D, Hernandez-Enriquez B, Wu X, Li R, Pan Z, Leveille J, Link CD, Oddo S, Sesti F. Toxic role of K+ channel oxidation in mammalian brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 4133-44. PMID 22442077 DOI: 10.1523/Jneurosci.6153-11.2012 |
0.439 |
|
| 2012 |
Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, Strong R, Richardson A, Oddo S. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling. Aging Cell. 11: 326-35. PMID 22212527 DOI: 10.1111/J.1474-9726.2011.00791.X |
0.333 |
|
| 2012 |
Oddo S. The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience (Scholar Edition). 4: 941-52. PMID 22202101 DOI: 10.2741/S310 |
0.502 |
|
| 2012 |
Caccamo A, Majumder S, Oddo S. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43. The American Journal of Pathology. 180: 293-302. PMID 22067910 DOI: 10.1016/J.Ajpath.2011.09.022 |
0.434 |
|
| 2012 |
Cai Y, Zhang XM, Macklin LN, Cai H, Luo XG, Oddo S, Laferla FM, Struble RG, Rose GM, Patrylo PR, Yan XX. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology. Neurotoxicity Research. 21: 160-74. PMID 21725719 DOI: 10.1007/S12640-011-9256-9 |
0.615 |
|
| 2012 |
Edrey Y, Caccamo A, Oddo S, Buffenstein R. P4-283: High levels of BETA-AMYLOID and oxidative stress with no evidence of Alzheimer's disease-like pathology in the longest-lived rodent Alzheimer's & Dementia. 8: S757-S757. DOI: 10.1016/J.Jalz.2013.08.064 |
0.446 |
|
| 2012 |
Oddo S. O4-07-05: The role of mTOR in Alzheimer's disease: Lessons from animal models Alzheimer's & Dementia. 8: P628-P628. DOI: 10.1016/J.Jalz.2012.05.1675 |
0.38 |
|
| 2011 |
Majumder S, Richardson A, Strong R, Oddo S. Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. Plos One. 6: e25416. PMID 21980451 DOI: 10.1371/Journal.Pone.0025416 |
0.562 |
|
| 2011 |
Bianchi FT, Camera P, Ala U, Imperiale D, Migheli A, Boda E, Tempia F, Berto G, Bosio Y, Oddo S, LaFerla FM, Taraglio S, Dotti CG, Di Cunto F. The collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptides. Plos One. 6: e22370. PMID 21829458 DOI: 10.1371/Journal.Pone.0022370 |
0.664 |
|
| 2011 |
Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magrà A, Oddo S. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. The Journal of Biological Chemistry. 286: 8924-32. PMID 21266573 DOI: 10.1074/Jbc.M110.180638 |
0.567 |
|
| 2011 |
Medina DX, Caccamo A, Oddo S. Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathology (Zurich, Switzerland). 21: 140-9. PMID 20731659 DOI: 10.1111/J.1750-3639.2010.00430.X |
0.541 |
|
| 2010 |
Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 22687-92. PMID 21149712 DOI: 10.1073/Pnas.1012851108 |
0.502 |
|
| 2010 |
Caccamo A, Magrí A, Oddo S. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation. Molecular Neurodegeneration. 5: 51. PMID 21070634 DOI: 10.1186/1750-1326-5-51 |
0.557 |
|
| 2010 |
Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. The Journal of Biological Chemistry. 285: 13107-20. PMID 20178983 DOI: 10.1074/Jbc.M110.100420 |
0.523 |
|
| 2010 |
Bryleva EY, Rogers MA, Chang CC, Buen F, Harris BT, Rousselet E, Seidah NG, Oddo S, LaFerla FM, Spencer TA, Hickey WF, Chang TY. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proceedings of the National Academy of Sciences of the United States of America. 107: 3081-6. PMID 20133765 DOI: 10.1073/Pnas.0913828107 |
0.672 |
|
| 2010 |
Nakashima AS, Oddo S, Laferla FM, Dyck RH. Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice. Neurobiology of Aging. 31: 605-13. PMID 18603329 DOI: 10.1016/J.Neurobiolaging.2008.05.028 |
0.643 |
|
| 2010 |
Oddo S. S5-01-04: Molecular interplay between mTOR, Aβ and tau: Effects on cognitive impairments Alzheimer's & Dementia. 6: S167-S167. DOI: 10.1016/J.Jalz.2010.05.519 |
0.415 |
|
| 2010 |
Rogers M, Bryleva E, Chang C, Buen F, Harris B, Rousselet E, Seidah N, Oddo S, LaFerla F, Spencer T, Hickey W, Chang TY. P3-285: ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in Alzheimer mice Alzheimer's & Dementia. 6: S535-S535. DOI: 10.1016/J.Jalz.2010.05.1785 |
0.658 |
|
| 2009 |
Bourasset F, Ouellet M, Tremblay C, Julien C, Do TM, Oddo S, LaFerla F, Calon F. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease. Neuropharmacology. 56: 808-13. PMID 19705573 DOI: 10.1016/J.Neuropharm.2009.01.006 |
0.671 |
|
| 2009 |
Caccamo A, Majumder S, Deng JJ, Bai Y, Thornton FB, Oddo S. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. The Journal of Biological Chemistry. 284: 27416-24. PMID 19651785 DOI: 10.1074/Jbc.M109.031278 |
0.385 |
|
| 2009 |
Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, LaFerla F, Bazinet RP, Calon F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochemistry International. 55: 476-82. PMID 19442696 DOI: 10.1016/J.Neuint.2009.04.018 |
0.505 |
|
| 2009 |
McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton-Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, Tansey MG. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiology of Disease. 34: 163-77. PMID 19320056 DOI: 10.1016/J.Nbd.2009.01.006 |
0.776 |
|
| 2009 |
Nuntagij P, Oddo S, LaFerla FM, Kotchabhakdi N, Ottersen OP, Torp R. Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canines. Journal of Alzheimer's Disease : Jad. 16: 315-23. PMID 19221421 DOI: 10.3233/Jad-2009-0962 |
0.654 |
|
| 2009 |
Guan H, Liu Y, Daily A, Police S, Kim MH, Oddo S, LaFerla FM, Pauly JR, Murphy MP, Hersh LB. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease. Journal of Neuroscience Research. 87: 1462-73. PMID 19021293 DOI: 10.1002/Jnr.21944 |
0.655 |
|
| 2009 |
Gulinello M, Gertner M, Mendoza G, Schoenfeld BP, Oddo S, LaFerla F, Choi CH, McBride SM, Faber DS. Validation of a 2-day water maze protocol in mice. Behavioural Brain Research. 196: 220-7. PMID 18831990 DOI: 10.1016/J.Bbr.2008.09.002 |
0.568 |
|
| 2009 |
Oddo S, Caccamo A, Cheng D, LaFerla FM. Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology. Brain Pathology (Zurich, Switzerland). 19: 421-30. PMID 18657136 DOI: 10.1111/J.1750-3639.2008.00194.X |
0.688 |
|
| 2009 |
Nuntagij P, Oddo S, LaFerla FM, Kotchabhakdi N, Ottersen OP, Torp R. P2-139: Amyloid plaques are formed in association with specific plasma membrane domains: An EM-immunogold 3-D-reconstruction study Alzheimer's & Dementia. 5: P302-P302. DOI: 10.1016/J.Jalz.2009.04.450 |
0.524 |
|
| 2008 |
Oddo S, Caccamo A, Tseng B, Cheng D, Vasilevko V, Cribbs DH, LaFerla FM. Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12163-75. PMID 19020010 DOI: 10.1523/Jneurosci.2464-08.2008 |
0.84 |
|
| 2008 |
Janelsins MC, Mastrangelo MA, Park KM, Sudol KL, Narrow WC, Oddo S, LaFerla FM, Callahan LM, Federoff HJ, Bowers WJ. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. The American Journal of Pathology. 173: 1768-82. PMID 18974297 DOI: 10.2353/Ajpath.2008.080528 |
0.65 |
|
| 2008 |
Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. Plos One. 3: e2935. PMID 18698410 DOI: 10.1371/Journal.Pone.0002935 |
0.699 |
|
| 2008 |
McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, LaFerla FM, Jenkins BG, Kowall NW, Dedeoglu A. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Research. 1207: 225-36. PMID 18374906 DOI: 10.1016/J.Brainres.2008.01.095 |
0.711 |
|
| 2008 |
Oddo S. The ubiquitin-proteasome system in Alzheimer's disease. Journal of Cellular and Molecular Medicine. 12: 363-73. PMID 18266959 DOI: 10.1111/J.1582-4934.2008.00276.X |
0.546 |
|
| 2008 |
Lopez JR, Lyckman A, Oddo S, Laferla FM, Querfurth HW, Shtifman A. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. Journal of Neurochemistry. 105: 262-71. PMID 18021291 DOI: 10.1111/J.1471-4159.2007.05135.X |
0.575 |
|
| 2008 |
Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, Kung HF, Lam KS, Oddo S, Laferla FM, Jin LW. Congo red and thioflavin-T analogs detect Abeta oligomers. Journal of Neurochemistry. 104: 457-68. PMID 17953662 DOI: 10.1111/J.1471-4159.2007.04972.X |
0.62 |
|
| 2008 |
Oddo S, Caccamo A, Tseng B, Cheng D, Vasilevko V, Cribbs DH, LaFerla FM. O2-02-06: Blocking Aβ42 accumulation delays the onset and progression of Tau pathology and cognitive decline via CHIP: A mechanistic link between Aβ and Tau pathology Alzheimer's & Dementia. 4: T134-T134. DOI: 10.1016/J.Jalz.2008.05.318 |
0.649 |
|
| 2008 |
Coakley MF, Moloney AM, Oddo S, LaFerla FM, O' Neill C. P4-251: Changes in Akt and IGF-1 receptor signaling relate to developing Abeta and tangle pathology in the triple transgenic model of Alzheimer's disease Alzheimer's & Dementia. 4: T745-T745. DOI: 10.1016/J.Jalz.2008.05.2320 |
0.638 |
|
| 2008 |
Liu Y, Guan H, Klein RL, Oddo S, LaFerla FM, Murphy MP, Hersh LB. P2-343: Peripherally overexpessed neprilysin in muscle reduces brain amyloid in a transgenic mouse model of AD Alzheimer's & Dementia. 4: T473-T473. DOI: 10.1016/J.Jalz.2008.05.1420 |
0.5 |
|
| 2007 |
Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13357-65. PMID 18045930 DOI: 10.1523/Jneurosci.2718-07.2007 |
0.682 |
|
| 2007 |
Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM. Neural stem cells improve memory in an inducible mouse model of neuronal loss. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11925-33. PMID 17978032 DOI: 10.1523/Jneurosci.1627-07.2007 |
0.738 |
|
| 2007 |
Cole AR, Noble W, van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, et al. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. Journal of Neurochemistry. 103: 1132-44. PMID 17683481 DOI: 10.1111/J.1471-4159.2007.04829.X |
0.696 |
|
| 2007 |
Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, McGaugh JL, LaFerla FM. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiology of Disease. 28: 76-82. PMID 17659878 DOI: 10.1016/J.Nbd.2007.06.013 |
0.79 |
|
| 2007 |
LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nature Reviews. Neuroscience. 8: 499-509. PMID 17551515 DOI: 10.1038/Nrn2168 |
0.727 |
|
| 2007 |
Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Journal of Neurochemistry. 102: 1053-63. PMID 17472708 DOI: 10.1111/J.1471-4159.2007.04607.X |
0.711 |
|
| 2007 |
Caccamo A, Oddo S, Tran LX, LaFerla FM. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. The American Journal of Pathology. 170: 1669-75. PMID 17456772 DOI: 10.2353/Ajpath.2007.061178 |
0.647 |
|
| 2007 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Annals of the New York Academy of Sciences. 1097: 265-77. PMID 17413028 DOI: 10.1196/Annals.1379.025 |
0.575 |
|
| 2007 |
Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neuroscience and Biobehavioral Reviews. 31: 125-47. PMID 17055579 DOI: 10.1016/J.Neubiorev.2006.07.007 |
0.721 |
|
| 2006 |
Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13384-9. PMID 17182789 DOI: 10.1523/Jneurosci.2514-06.2006 |
0.709 |
|
| 2006 |
Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. The Journal of Biological Chemistry. 281: 39413-23. PMID 17056594 DOI: 10.1074/Jbc.M608485200 |
0.705 |
|
| 2006 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5180-9. PMID 16687509 DOI: 10.1523/Jneurosci.0739-06.2006 |
0.627 |
|
| 2006 |
Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron. 49: 671-82. PMID 16504943 DOI: 10.1016/J.Neuron.2006.01.020 |
0.743 |
|
| 2006 |
Oddo S, LaFerla FM. The role of nicotinic acetylcholine receptors in Alzheimer's disease. Journal of Physiology, Paris. 99: 172-9. PMID 16448808 DOI: 10.1016/J.Jphysparis.2005.12.080 |
0.695 |
|
| 2006 |
Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM. A dynamic relationship between intracellular and extracellular pools of Abeta. The American Journal of Pathology. 168: 184-94. PMID 16400022 DOI: 10.2353/Ajpath.2006.050593 |
0.738 |
|
| 2006 |
Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. The Journal of Biological Chemistry. 281: 1599-604. PMID 16282321 DOI: 10.1074/Jbc.M507892200 |
0.7 |
|
| 2006 |
Janelsins MC, Mastrangelo MA, Park KM, Fowlkes KL, Kinsky M, Narrow WC, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ. 248. Revealing the Role(s) of TNF-alpha in Early Alzheimer's Disease Via rAAV-Mediated Hippocampal Gene Transfer in a Triple Transgenic Mouse Model Molecular Therapy. 13: S95. DOI: 10.1016/J.Ymthe.2006.08.275 |
0.671 |
|
| 2006 |
Caccamo A, Oddo S, Fisher A, LaFerla FM. P1-451: M1 receptors play a central role in modulating AD-like pathology in transgenic mice Alzheimer's & Dementia. 2: S230-S230. DOI: 10.1016/J.Jalz.2006.05.830 |
0.619 |
|
| 2006 |
Rosario ER, Carroll JC, Chang L, Stanczyk F, Oddo S, LaFerla F, Pike CJ. P1-252: Androgens regulate development of neuropathology in a mouse model of Alzheimer's disease Alzheimer's & Dementia. 2: S170-S170. DOI: 10.1016/J.Jalz.2006.05.629 |
0.611 |
|
| 2006 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, LaFerla F, Parker I. P1-125: Enhanced ryanodine receptor recruitment contributes to Ca2+
disruptions in young, adult and aged Alzheimer disease mice Alzheimer's & Dementia. 2: S132-S132. DOI: 10.1016/J.Jalz.2006.05.501 |
0.592 |
|
| 2006 |
Gimenez-Llort L, Blazquez G, Canete T, Rosa R, Vivo M, Oddo S, Navarro X, LaFerla FM, Johansson B, Tobena A, Fernandez-Teruel A. P1-124: Modeling neuropsychiatric symptoms of Alzheimer's dementia in 3xTgAD mice Alzheimer's & Dementia. 2: S132-S132. DOI: 10.1016/J.Jalz.2006.05.500 |
0.431 |
|
| 2006 |
Fisher A, Caccamo A, Oddo S, Billings LM, Green KN, Brandeis R, Pittel Z, Barner N, Elkon H, Laferla FM. S4-04-02: M1 muscarinic agonists as a comprehensive therapy in Alzheimer's disease Alzheimer's & Dementia. 2: S73-S73. DOI: 10.1016/J.Jalz.2006.05.285 |
0.525 |
|
| 2006 |
Hersh LB, Guan H, Daily A, Murphy MP, Oddo S, LaFerla FM. O2-05-01: Peripheral expression of neprilysin decreases amyloid deposition in hAPP mice Alzheimer's & Dementia. 2: S39-S40. DOI: 10.1016/J.Jalz.2006.05.138 |
0.592 |
|
| 2006 |
Oddo S, Caccamo A, Vasilevko V, Cribbs DH, LaFerla FM. O1-06-04: Reduction of both soluble Aβ and tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles Alzheimer's & Dementia. 2: S21-S21. DOI: 10.1016/J.Jalz.2006.05.064 |
0.67 |
|
| 2005 |
Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. Journal of Neuroinflammation. 2: 23. PMID 16232318 DOI: 10.1186/1742-2094-2-23 |
0.706 |
|
| 2005 |
Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8843-53. PMID 16192374 DOI: 10.1523/Jneurosci.2868-05.2005 |
0.828 |
|
| 2005 |
Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. Journal of Neurochemistry. 94: 1711-8. PMID 16156741 DOI: 10.1111/J.1471-4159.2005.03332.X |
0.698 |
|
| 2005 |
LaFerla FM, Oddo S. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends in Molecular Medicine. 11: 170-6. PMID 15823755 DOI: 10.1016/J.Molmed.2005.02.009 |
0.687 |
|
| 2005 |
Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 45: 675-88. PMID 15748844 DOI: 10.1016/J.Neuron.2005.01.040 |
0.719 |
|
| 2005 |
Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiology of Aging. 26: 645-54. PMID 15708439 DOI: 10.1016/J.Neurobiolaging.2004.06.013 |
0.791 |
|
| 2005 |
Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 3046-51. PMID 15705720 DOI: 10.1073/Pnas.0408500102 |
0.739 |
|
| 2004 |
Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 43: 321-32. PMID 15294141 DOI: 10.1016/J.Neuron.2004.07.003 |
0.694 |
|
| 2004 |
Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. The Journal of Clinical Investigation. 114: 121-30. PMID 15232619 DOI: 10.1172/Jci20640 |
0.799 |
|
| 2004 |
Shakkottai VG, Chou CH, Oddo S, Sailer CA, Knaus HG, Gutman GA, Barish ME, LaFerla FM, Chandy KG. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. The Journal of Clinical Investigation. 113: 582-90. PMID 14966567 DOI: 10.1172/Jci200420216 |
0.54 |
|
| 2004 |
Agadjanyan MG, Petrushina I, Ghochikyan A, Vasilevko V, Movsesyan N, Oddo S, LaFerla FM, Cribbs DH. P4-385 Alzheimer's epitope vaccine based on the dominant B cell epitope of Aβ and padre, a foreign T cell epitope Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81943-2 |
0.346 |
|
| 2004 |
Oddo S, Billings LM, LaFerla FM. P4-371 In vivo evidence linking Aβ and TAU Neurobiology of Aging. 25: S580. DOI: 10.1016/S0197-4580(04)81929-8 |
0.635 |
|
| 2004 |
Smith IF, Oddo S, Green KN, LaFerla FM. P2-119 Alterations of intracellular CA2+ homeostasis in a triple transgenic model (PS1M146V, APPSWE, TAUP301L) of Alzheimer's disease Neurobiology of Aging. 25: S258. DOI: 10.1016/S0197-4580(04)80866-2 |
0.683 |
|
| 2004 |
Billings LM, Oddo S, LaFerla FM. P2-073 Assessing cognitive impairments in the 3XTG-AD mice: correlations with plaque and tangle pathology Neurobiology of Aging. 25: S244-S245. DOI: 10.1016/S0197-4580(04)80820-0 |
0.649 |
|
| 2004 |
Furukawa K, Wang Y, Yao PJ, Mattson MP, Oddo S, LaFerla FM. P2-071 Ion channel properties of neurons from APP/PS1/TAU triple mutant mice Neurobiology of Aging. 25: S244. DOI: 10.1016/S0197-4580(04)80818-2 |
0.563 |
|
| 2004 |
Akbari Y, Dagher N, Murphy MP, Kozak JA, Hitt B, Oddo S, Tseng B, Golde TE, Cahalan M, Leissring MA, M. LaFerla F. P1-206 Capacitative and non-capacitative Ca2+ entry modulate Aβ levels Neurobiology of Aging. 25: S154-S155. DOI: 10.1016/S0197-4580(04)80519-0 |
0.766 |
|
| 2004 |
LaFerla FM, Oddo S, Billings LM. O1-04-08 Antibody-mediated clearance of beta-amyloid reverses early TAU aggregates, but not late, hyperphosphorylated TAU Neurobiology of Aging. 25: S18. DOI: 10.1016/S0197-4580(04)80059-9 |
0.605 |
|
| 2003 |
Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiology of Aging. 24: 1063-70. PMID 14643377 DOI: 10.1016/J.Neurobiolaging.2003.08.012 |
0.853 |
|
| 2003 |
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 39: 409-21. PMID 12895417 DOI: 10.1016/S0896-6273(03)00434-3 |
0.823 |
|
| 2002 |
Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, LaFerla FM. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 99: 6334-9. PMID 11972038 DOI: 10.1073/Pnas.082545599 |
0.79 |
|
| Show low-probability matches. |